LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
MCF 10A	Seliciclib	3.33	uM	LJP5	3	J02	72	hr	513	8348	10483	0.7963	0.8980
MCF 10A	AT-7519	0.12	uM	LJP6	2	K05	72	hr	513	7335	10386	0.7062	0.8459
MCF 10A	Seliciclib	0.37	uM	LJP5	1	J04	72	hr	513	9708	10254	0.9467	0.9748
MCF 10A	Seliciclib	3.33	uM	LJP5	2	J02	72	hr	513	9171	10349	0.8861	0.9450
MCF 10A	AT-7519	0.04	uM	LJP6	1	K06	72	hr	513	9715	10537	0.9219	0.9630
MCF 10A	AT-7519	0.12	uM	LJP6	1	K05	72	hr	513	8639	10537	0.8198	0.9109
MCF 10A	Seliciclib	0.04	uM	LJP5	3	J06	72	hr	513	10316	10483	0.9840	0.9926
MCF 10A	Seliciclib	0.12	uM	LJP5	3	J05	72	hr	513	9726	10483	0.9277	0.9658
MCF 10A	Seliciclib	1.11	uM	LJP5	1	J03	72	hr	513	10135	10254	0.9883	0.9946
MCF 10A	Seliciclib	3.33	uM	LJP5	1	J02	72	hr	513	8364	10254	0.8156	0.9078
MCF 10A	Seliciclib	10	uM	LJP5	2	J01	72	hr	513	1230	10349	0.1189	0.2234
MCF 10A	Seliciclib	10	uM	LJP5	3	J01	72	hr	513	1525	10483	0.1455	0.2843
MCF 10A	AT-7519	0.04	uM	LJP6	2	K06	72	hr	513	10001	10386	0.9629	0.9826
MCF 10A	AT-7519	0.04	uM	LJP6	3	K06	72	hr	513	10020	10494	0.9548	0.9789
MCF 10A	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	513	10248	10254	0.9993	0.9997
MCF 10A	Seliciclib	0.04	uM	LJP5	2	J06	72	hr	513	10376	10349	1.0026	1.0012
MCF 10A	Seliciclib	0.12	uM	LJP5	1	J05	72	hr	513	9702	10254	0.9461	0.9745
MCF 10A	Seliciclib	0.12	uM	LJP5	2	J05	72	hr	513	10502	10349	1.0147	1.0068
MCF 10A	Seliciclib	0.37	uM	LJP5	2	J04	72	hr	513	9644	10349	0.9318	0.9677
MCF 10A	Seliciclib	0.37	uM	LJP5	3	J04	72	hr	513	9730	10483	0.9281	0.9660
MCF 10A	Seliciclib	1.11	uM	LJP5	2	J03	72	hr	513	9317	10349	0.9002	0.9521
MCF 10A	Seliciclib	1.11	uM	LJP5	3	J03	72	hr	513	9380	10483	0.8947	0.9495
MCF 10A	Seliciclib	10	uM	LJP5	1	J01	72	hr	513	1052	10254	0.1026	0.1807
MCF 10A	AT-7519	0.37	uM	LJP6	1	K04	72	hr	513	943	10537	0.0895	0.1497
MCF 10A	AT-7519	0.12	uM	LJP6	3	K05	72	hr	513	7582	10494	0.7225	0.8561

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)